SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    G. Madeo, T. Schirinzi, M. Maltese, G. Martella, C. Rapino, F. Fezza, N. Mastrangelo, P. Bonsi, M. Maccarrone, A. Pisani, Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice, Neuropharmacology, 2016, 101, 460

    CrossRef

  2. 2
    Heather McCann, Heidi Cartwright, Glenda M. Halliday, Neuropathology of α-synuclein propagation and braak hypothesis, Movement Disorders, 2016, 31, 2
  3. 3
    Amy M. Todd, Brian E. Staveley, <i>Pink</i>1 Rescues <i>Gal</i>4-Induced Developmental Defects in the <i>Drosophila</i> Eye, Advances in Parkinson's Disease, 2015, 04, 03, 43

    CrossRef

  4. 4
    Michaela E. Johnson, Larisa Bobrovskaya, An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions, NeuroToxicology, 2015, 46, 101

    CrossRef

  5. 5
    Li-Shou Pan, Zheng Wang, Dan Ding, Xue-Peng Zhu, Hui-Lin Leng, Xin-Bo Deng, Yan-Ming Xu, Lack of association between theATP13A2A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis, International Journal of Neuroscience, 2015, 1

    CrossRef

  6. 6
    Maria Vadalà, Annamaria Vallelunga, Lucia Palmieri, Beniamino Palmieri, Julio Cesar Morales-Medina, Tommaso Iannitti, Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson’s disease, Behavioral and Brain Functions, 2015, 11, 1

    CrossRef

  7. 7
    C. L. Nezich, C. Wang, A. I. Fogel, R. J. Youle, MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5, The Journal of Cell Biology, 2015, 210, 3, 435

    CrossRef

  8. 8
    Tomotake Kanki, Kentaro Furukawa, Shun-ichi Yamashita, Mitophagy in yeast: Molecular mechanisms and physiological role, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015, 1853, 10, 2756

    CrossRef

  9. 9
    Manuel Rodriguez, Clara Rodriguez-Sabate, Ingrid Morales, Alberto Sanchez, Magdalena Sabate, Parkinson's disease as a result of aging, Aging Cell, 2015, 14, 3
  10. 10
    Ming Ye, Dai Zhou, Youxin Zhou, Chunming Sun, Parkinson's disease-associated PINK1G309D mutation increases abnormal phosphorylation of Tau, IUBMB Life, 2015, 67, 4
  11. 11
    Mark G. Waugh, PIPs in neurological diseases, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2015, 1851, 8, 1066

    CrossRef

  12. 12
    Shang-Der Chen, Tsu-Kung Lin, Ding-I. Yang, Su-Ying Lee, Fu-Zen Shaw, Chia-Wei Liou, Yao-Chung Chuang, Roles of PTEN-induced putative kinase 1 and dynamin-related protein 1 in transient global ischemia-induced hippocampal neuronal injury, Biochemical and Biophysical Research Communications, 2015, 460, 2, 397

    CrossRef

  13. 13
    Lucas Nürnberger, Christine Klein, Simon Baudrexel, Julia Roggendorf, Marcel Hildner, Shu Chen, Jun-Suk Kang, Rüdiger Hilker, Johann Hagenah, Ultrasound-based motion analysis demonstrates bilateral arm hypokinesia during gait in heterozygous PINK1 mutation carriers, Movement Disorders, 2015, 30, 3
  14. 14
    Christian N. Cunningham, Joshua M. Baughman, Lilian Phu, Joy S. Tea, Christine Yu, Mary Coons, Donald S. Kirkpatrick, Baris Bingol, Jacob E. Corn, USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria, Nature Cell Biology, 2015, 17, 2, 160

    CrossRef

  15. 15
    Suzana Gispert, Georg Auburger, Korah P. Kuruvilla, Mark S. LeDoux, Movement Disorders, 2015,

    CrossRef

  16. 16
    Andrei Surguchov, 2015,

    CrossRef

  17. 17
    Paolo Calabresi, Veronica Ghiglieri, “Lazy” nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease, Movement Disorders, 2014, 29, 1
  18. 18
    Nele A. Haelterman, Wan Hee Yoon, Hector Sandoval, Manish Jaiswal, Joshua M. Shulman, Hugo J. Bellen, A Mitocentric View of Parkinson's Disease, Annual Review of Neuroscience, 2014, 37, 1, 137

    CrossRef

  19. 19
    Marusela Oliveras-Salvá, Francesca Macchi, Valérie Coessens, Angélique Deleersnijder, Melanie Gérard, Anke Van der Perren, Chris Van den Haute, Veerle Baekelandt, Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice, Neurobiology of Aging, 2014, 35, 11, 2625

    CrossRef

  20. 20
    Marco Bisaglia, Roberta Filograna, Mariano Beltramini, Luigi Bubacco, Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?, Ageing Research Reviews, 2014, 13, 107

    CrossRef

  21. 21
    Francisco Pan-Montojo, Heinz Reichmann, Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology, Translational Neurodegeneration, 2014, 3, 1, 10

    CrossRef

  22. 22
    Bill B. Chen, Tiffany A. Coon, Jennifer R. Glasser, Chunbin Zou, Bryon Ellis, Tuhin Das, Alison C. McKelvey, Shristi Rajbhandari, Travis Lear, Christelle Kamga, Sruti Shiva, Chenjian Li, Joseph M. Pilewski, Jason Callio, Charleen T. Chu, Anuradha Ray, Prabir Ray, Yulia Y. Tyurina, Valerian E. Kagan, Rama K. Mallampalli, E3 Ligase Subunit Fbxo15 and PINK1 Kinase Regulate Cardiolipin Synthase 1 Stability and Mitochondrial Function in Pneumonia, Cell Reports, 2014, 7, 2, 476

    CrossRef

  23. 23
    Dorthe Matenia, Eva M. Mandelkow, Emerging modes of PINK1 signaling: another task for MARK2, Frontiers in Molecular Neuroscience, 2014, 7,

    CrossRef

  24. 24
    D. R. Green, L. Galluzzi, G. Kroemer, Metabolic control of cell death, Science, 2014, 345, 6203, 1250256

    CrossRef

  25. 25
    Jacqueline A. Gleave, Peter D. Perri, Joanne E. Nash, Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection, Frontiers in Biology, 2014, 9, 6, 489

    CrossRef

  26. 26
    Zhi Dong Zhou, Fathima Shaffra Refai, Shao Ping Xie, Shin Hui Ng, Christine Hui Shan Chan, Patrick Ghim Hoe Ho, Xiao Dong Zhang, Tit Meng Lim, Eng King Tan, Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons, Free Radical Biology and Medicine, 2014, 68, 220

    CrossRef

  27. 27
    Werner J Geldenhuys, Samir M Abdelmagid, Patrick J Gallegos, Fayez F Safadi, Parkinson’s disease biomarker: a patent evaluation of WO2013153386, Expert Opinion on Therapeutic Patents, 2014, 24, 8, 947

    CrossRef

  28. 28
    Regina M. Carney, Martin A. Kohli, Brian W. Kunkle, Adam C. Naj, John R. Gilbert, Stephan Züchner, Margaret A. Pericak-Vance, Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation, Alzheimer's & Dementia, 2014, 10, 3, 360

    CrossRef

  29. 29
    Kuldip D. Dave, Shehan De Silva, Niketa P. Sheth, Sylvie Ramboz, Melissa J. Beck, Changyu Quang, Robert C. Switzer, Syed O. Ahmad, Susan M. Sunkin, Dan Walker, Xiaoxia Cui, Daniel A. Fisher, Aaron M. McCoy, Kevin Gamber, Xiaodong Ding, Matthew S. Goldberg, Stanley A. Benkovic, Meredith Haupt, Marco A.S. Baptista, Brian K. Fiske, Todd B. Sherer, Mark A. Frasier, Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease, Neurobiology of Disease, 2014, 70, 190

    CrossRef

  30. 30
    V. A. Morais, D. Haddad, K. Craessaerts, P.-J. De Bock, J. Swerts, S. Vilain, L. Aerts, L. Overbergh, A. Grunewald, P. Seibler, C. Klein, K. Gevaert, P. Verstreken, B. De Strooper, PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling, Science, 2014, 344, 6180, 203

    CrossRef

  31. 31
    Ciara H. O'Flanagan, Cora O'Neill, PINK1 signalling in cancer biology, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014, 1846, 2, 590

    CrossRef

  32. 32
    Juan Carlos Corona, Senio Campos de Souza, Michael R. Duchen, PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1, Experimental Neurology, 2014, 253, 16

    CrossRef

  33. 33
    Manuel Rodriguez, Ingrid Morales, Clara Rodriguez-Sabate, Alberto Sanchez, Rafael Castro, Jose Miguel Brito, Magdalena Sabate, The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging, Frontiers in Neuroanatomy, 2014, 8,

    CrossRef

  34. 34
    Xiaoling Duan, Jade Tong, Qin Xu, Yili Wu, Fang Cai, Tingyu Li, Weihong Song, Upregulation of human PINK1 gene expression by NFκB signalling, Molecular Brain, 2014, 7, 1

    CrossRef

  35. 35
    María F. Galindo, Maria E. Solesio, Joaquin Jordan, Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, 2014,

    CrossRef

  36. 36
    Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy, Biomarkers in Toxicology, 2014,

    CrossRef

  37. 37
    Amy M. Todd, Brian E. Staveley, <i>Pink1 </i>and <i>parkin</i> demonstrate multifaceted roles when co-expressed with <i>Foxo</i>, Advances in Parkinson's Disease, 2013, 02, 01, 5

    CrossRef

  38. 38
    Masaaki Waragai, Kazunari Sekiyama, Masayo Fujita, Takahiko Tokuda, Makoto Hashimoto, Biomarkers for the diagnosis and management of Parkinson's disease, Expert Opinion on Medical Diagnostics, 2013, 7, 1, 71

    CrossRef

  39. 39
    Karla Cristina Vasconcelos Moura, Mário Campos Junior, Ana Lúcia Zuma de Rosso, Denise Hack Nicaretta, João Santos Pereira, Delson José Silva, Flávia Lima dos Santos, Fabíola da Costa Rodrigues, Cíntia Barros Santos-Rebouças, Márcia Mattos Gonçalves Pimentel, Genetic Analysis ofPARK2andPINK1Genes in Brazilian Patients with Early-Onset Parkinson's Disease, Disease Markers, 2013, 35, 181

    CrossRef

  40. 40
    Wei-Lin Chien, Tzeng-Ruei Lee, Shih-Ya Hung, Kai-Hsiang Kang, Ruey-Meei Wu, Ming-Jen Lee, Wen-Mei Fu, Increase of oxidative stress by a novel PINK1 mutation, P209A, Free Radical Biology and Medicine, 2013, 58, 160

    CrossRef

  41. 41
    Xinmin Liu, Rong Cheng, Xin Ye, Miguel Verbitsky, Sergey Kisselev, Helen Mejia-Santana, Elan D. Louis, Lucien J. Cote, Howard F. Andrews, Cheryl H. Waters, Blair Ford, Stanley Fahn, Karen Marder, Joseph H. Lee, Lorraine N. Clark, Increased rate of sporadic and recurrent rare genic copy number variants in Parkinson's disease among Ashkenazi Jews, Molecular Genetics & Genomic Medicine, 2013, 1, 3
  42. 42
    Jia Li, Weidong Le, Modeling neurodegenerative diseases in Caenorhabditis elegans, Experimental Neurology, 2013, 250, 94

    CrossRef

  43. 43
    Jun Kim, Ji-Won Byun, Insup Choi, Beomsue Kim, Hey-Kyeong Jeong, Ilo Jou, Eunhye Joe, PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices, Experimental Neurobiology, 2013, 22, 1, 38

    CrossRef

  44. 44
    Chandra S Boosani, Devendra K Agrawal, PTEN modulators: a patent review, Expert Opinion on Therapeutic Patents, 2013, 23, 5, 569

    CrossRef

  45. 45
    Jianjun Sun, Evguenia Kouranova, Xiaoxia Cui, Robert H. Mach, Jinbin Xu, Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats, Neuroscience Letters, 2013, 557, 123

    CrossRef

  46. 46
    Rita Perfeito, Teresa Cunha-Oliveira, Ana Cristina Rego, Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse, Free Radical Biology and Medicine, 2013, 62, 186

    CrossRef

  47. 47
    Shinsuke Fujioka, Christina Sundal, Owen A. Ross, Zbigniew K. Wszolek, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  48. 48
    Shinsuke Fujioka, Christina Sundal, Owen Ross, Zbigniew Wszolek, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  49. 49
    Yoshikuni Mizuno, An update on the management of juvenile and young-onset Parkinson’s disease, Future Neurology, 2012, 7, 5, 581

    CrossRef

  50. 50
    Yong Huang, Sushila Shenoy, Bingwei Lu, Wencheng Liu, Chenjian Li, Kinase Signaling Dysfunction in Parkinson's Disease: A Reverse Genetic Approach inDrosophila, Journal of Neurogenetics, 2012, 26, 2, 158

    CrossRef

  51. 51
    D. Santos, S.M. Cardoso, Mitochondrial dynamics and neuronal fate in Parkinson's disease, Mitochondrion, 2012, 12, 4, 428

    CrossRef

  52. 52
    J. Drouin-Ouellet, R. A. Barker, Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?, Stem Cells International, 2012, 2012, 1

    CrossRef

  53. 53
    D. Allan Butterfield, Marzia Perluigi, Tanea Reed, Tasneem Muharib, Christopher P. Hughes, Renã A.S. Robinson, Rukhsana Sultana, Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications, Antioxidants & Redox Signaling, 2012, 17, 11, 1610

    CrossRef

  54. 54
    Rita Perfeito, Teresa Cunha-Oliveira, Ana Cristina Rego, Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse, Free Radical Biology and Medicine, 2012, 53, 9, 1791

    CrossRef

  55. 55
    Gaynor A. Smith, Ole Isacson, Stephen B. Dunnett, The search for genetic mouse models of prodromal Parkinson's disease, Experimental Neurology, 2012, 237, 2, 267

    CrossRef

  56. 56
    Anthony Schapira, Mitochondrial Signaling in Health and Disease, 2012,

    CrossRef

  57. 57
    Rejko Krüger, Manu Sharma, Olaf Riess, Thomas Gasser, Christine Van Broeckhoven, Jessie Theuns, Jan Aasly, Grazia Annesi, Anna Rita Bentivoglio, Alexis Brice, Ana Djarmati, Alexis Elbaz, Matthew Farrer, Carlo Ferrarese, J. Mark Gibson, Georgios M. Hadjigeorgiou, Nobutaka Hattori, John P.A. Ioannidis, Barbara Jasinska-Myga, Christine Klein, Jean-Charles Lambert, Suzanne Lesage, Juei-Jueng Lin, Timothy Lynch, George D. Mellick, Francesa de Nigris, Grzegorz Opala, Alessandro Prigione, Aldo Quattrone, Owen A. Ross, Wataru Satake, Peter A. Silburn, Eng King Tan, Tatsushi Toda, Hiroyuki Tomiyama, Karin Wirdefeldt, Zbigniew Wszolek, Georgia Xiromerisiou, Demetrius M. Maraganore, A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease, Neurobiology of Aging, 2011, 32, 3, 548.e9

    CrossRef

  58. 58
    G. Martella, G. Madeo, T. Schirinzi, A. Tassone, G. Sciamanna, F. Spadoni, A. Stefani, J. Shen, A. Pisani, P. Bonsi, Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease, Neuroscience, 2011, 177, 240

    CrossRef

  59. 59
    I. O. Suchkova, D. M. Shubina, A. F. Yakimovskii, E. V. Borisova, N. G. Eliseeva, L. K. Sasina, T. V. Baranova, V. S. Baranov, E. L. Patkin, Analysis of the association of minisatellite UPS29 of CENTB5 gene with Parkinson’s disease, Russian Journal of Genetics: Applied Research, 2011, 1, 2, 128

    CrossRef

  60. 60
    Madeleine Diedrich, Tohru Kitada, Grit Nebrich, Andrea Koppelstaetter, Jie Shen, Claus Zabel, Joachim Klose, Lei Mao, Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease, Proteome Science, 2011, 9, 1, 59

    CrossRef

  61. 61
    Maria Anfossi, Romina Vuono, Raffaele Maletta, Kanwar Virdee, Maria Mirabelli, Rosanna Colao, Gianfranco Puccio, Livia Bernardi, Francesca Frangipane, Maura Gallo, Silvana Geracitano, Carmine Tomaino, Sabrina Anna Maria Curcio, Giuseppa Zannino, Francesco Lamenza, Charles Duyckaerts, Maria Grazia Spillantini, Maria Adele Losso, Amalia C. Bruni, Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia, Neurobiology of Aging, 2011, 32, 4, 757.e1

    CrossRef

  62. 62
    Lena F. Burbulla, Rejko Krüger, Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease, Journal of the Neurological Sciences, 2011, 306, 1-2, 1

    CrossRef

  63. 63
    Ayse Ulusoy, Deniz Kirik, Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for Parkinson’s disease, Therapeutic Delivery, 2011, 2, 1, 37

    CrossRef

  64. 64
    Karin Wirdefeldt, Hans-Olov Adami, Philip Cole, Dimitrios Trichopoulos, Jack Mandel, Epidemiology and etiology of Parkinson’s disease: a review of the evidence, European Journal of Epidemiology, 2011, 26, S1, 1

    CrossRef

  65. 65
    Marta d’Amora, Cristiano Angelini, Manuela Marcoli, Chiara Cervetto, Tohru Kitada, Mauro Vallarino, Expression of PINK1 in the brain, eye and ear of mouse during embryonic development, Journal of Chemical Neuroanatomy, 2011, 41, 2, 73

    CrossRef

  66. 66
    Caroline Fernandes, Yong Rao, Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila, Molecular Brain, 2011, 4, 1, 17

    CrossRef

  67. 67
    Anthony H. V. Schapira, Matthew Gegg, Mitochondrial Contribution to Parkinson's Disease Pathogenesis, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  68. 68
    O. A. Buneeva, A. E. Medvedev, Mitochondrial dysfunction in Parkinson’s disease, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2011, 5, 4, 313

    CrossRef

  69. You have free access to this content69
    Anthony H. V. Schapira, Mitochondrial Pathology in Parkinson's Disease, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 6
  70. 70
    R K Dagda, A M Gusdon, I Pien, S Strack, S Green, C Li, B Van Houten, S J Cherra, C T Chu, Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease, Cell Death and Differentiation, 2011, 18, 12, 1914

    CrossRef

  71. 71
    An Zhou, Danmin Pan, Xiaoming Yang, Jianhua Zhou, Overexpression of Nrdp1/FLRF sensitizes cells to oxidative stress, Biochemical and Biophysical Research Communications, 2011, 410, 4, 771

    CrossRef

  72. 72
    Fernando Cardona, Jose Vicente Sánchez-Mut, Hernán Dopazo, Jordi Pérez-Tur, Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1, Human Mutation, 2011, 32, 4
  73. 73
    E. Deas, H. Plun-Favreau, S. Gandhi, H. Desmond, S. Kjaer, S. H. Y. Loh, A. E. M. Renton, R. J. Harvey, A. J. Whitworth, L. M. Martins, A. Y. Abramov, N. W. Wood, PINK1 cleavage at position A103 by the mitochondrial protease PARL, Human Molecular Genetics, 2011, 20, 5, 867

    CrossRef

  74. 74
    Brandon K. Harvey, Christopher T. Richie, Barry J. Hoffer, Mikko Airavaara, Transgenic animal models of neurodegeneration based on human genetic studies, Journal of Neural Transmission, 2011, 118, 1, 27

    CrossRef

  75. 75
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  76. 76
    Violeta Ruipérez, Frédéric Darios, Bazbek Davletov, Alpha-synuclein, lipids and Parkinson’s disease, Progress in Lipid Research, 2010, 49, 4, 420

    CrossRef

  77. 77
    Rowena J. Keyser, Suzanne Lesage, Alexis Brice, Jonathan Carr, Soraya Bardien, Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson’s disease, Biochemical and Biophysical Research Communications, 2010, 398, 1, 125

    CrossRef

  78. 78
    Patrizia Tarantino, Donatella Civitelli, Ferdinanda Annesi, Elvira V. De Marco, Francesca E. Rocca, Pierfrancesco Pugliese, Giuseppe Nicoletti, Sara Carrideo, Giovanni Provenzano, Grazia Annesi, Aldo Quattrone, Author’s reply to the comment of Sironi et al. on “Compound heterozygosity in DJ-1 gene non-coding portion related to Parkinsonism”, Parkinsonism & Related Disorders, 2010, 16, 5, 362

    CrossRef

  79. 79
    Grisel Lopez, Ellen Sidransky, Autosomal recessive mutations in the development of Parkinson’s disease, Biomarkers in Medicine, 2010, 4, 5, 713

    CrossRef

  80. 80
    Lena F. Burbulla, Guido Krebiehl, Rejko Krüger, Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease, European Journal of Clinical Investigation, 2010, 40, 11
  81. 81
    S. Lesage, A. Brice, Bases moléculaires de la maladie de Parkinson, EMC - Neurologie, 2010, 7, 1, 1

    CrossRef

  82. 82
    S. Lesage, A. Brice, Basi molecolari del morbo di Parkinson, EMC - Neurologia, 2010, 10, 2, 1

    CrossRef

  83. You have free access to this content83
    Adam J. Harrington, Shusei Hamamichi, Guy A. Caldwell, Kim A. Caldwell, C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease, Developmental Dynamics, 2010, 239, 5
  84. 84
    L. F. Burbulla, C. Schelling, H. Kato, D. Rapaport, D. Woitalla, C. Schiesling, C. Schulte, M. Sharma, T. Illig, P. Bauer, S. Jung, A. Nordheim, L. Schols, O. Riess, R. Kruger, Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis, Human Molecular Genetics, 2010, 19, 22, 4437

    CrossRef

  85. 85
    Arindam Biswas, Tamal Sadhukhan, Sayantani Majumder, Amar K. Misra, Shyamal K. Das, Indian Genome Variation Consortium, Kunal Ray, Jharna Ray, Evaluation of PINK1 variants in Indian Parkinson's disease patients, Parkinsonism & Related Disorders, 2010, 16, 3, 167

    CrossRef

  86. 86
    John Hardy, Genetic Analysis of Pathways to Parkinson Disease, Neuron, 2010, 68, 2, 201

    CrossRef

  87. 87
    Georgia Xiromerisiou, Efthimios Dardiotis, Vaïa Tsimourtou, Persa Maria Kountra, Konstantinos N. Paterakis, Eftychia Z. Kapsalaki, Kostas N. Fountas, Georgios M. Hadjigeorgiou, Genetic basis of Parkinson disease, Neurosurgical FOCUS, 2010, 28, 1, E7

    CrossRef

  88. 88
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  89. 89
    Inês Pimenta de Castro, L. Miguel Martins, Roberta Tufi, Mitochondrial quality control and neurological disease: an emerging connection, Expert Reviews in Molecular Medicine, 2010, 12,

    CrossRef

  90. 90
    Bao-rong Zhang, Zheng-xiang Hu, Xin-zhen Yin, Miao Cai, Guo-hua Zhao, Zhi-rong Liu, Wei Luo, Mutation analysis of parkin and PINK1 genes in early-onset Parkinson's disease in China, Neuroscience Letters, 2010, 477, 1, 19

    CrossRef

  91. 91
    Ji-feng Guo, Xue-wei Zhang, Li-luo Nie, Hai-nan Zhang, Bin Liao, Jing Li, Lei Wang, Xin-xiang Yan, Bei-sha Tang, Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism, Journal of Neurology, 2010, 257, 7, 1170

    CrossRef

  92. 92
    Marie Westerlund, Barry Hoffer, Lars Olson, Parkinson's disease: Exit toxins, enter genetics, Progress in Neurobiology, 2010, 90, 2, 146

    CrossRef

  93. 93
    Rina Bandopadhyay, Jacqueline de Belleroche, Pathogenesis of Parkinson's disease: emerging role of molecular chaperones, Trends in Molecular Medicine, 2010, 16, 1, 27

    CrossRef

  94. 94
    Clecio Godeiro, Patricia M. de Carvalho Aguiar, Andre C. Felício, Orlando G.P. Barsottini, Sonia M.A. Silva, Vanderci Borges, Luiz Augusto F. Andrade, Henrique Ballalai Ferraz, PINK1 polymorphism IVS1−7 A[RIGHTWARDS ARROW]G, exposure to environmental risk factors and anticipation of disease onset in Brazilian patients with early-onset Parkinson's Disease, Neuroscience Letters, 2010, 469, 1, 155

    CrossRef

  95. 95
    L. Samaranch, O. Lorenzo-Betancor, J. M. Arbelo, I. Ferrer, E. Lorenzo, J. Irigoyen, M. A. Pastor, C. Marrero, C. Isla, J. Herrera-Henriquez, P. Pastor, PINK1-linked parkinsonism is associated with Lewy body pathology, Brain, 2010, 133, 4, 1128

    CrossRef

  96. 96
    Carlo Rodolfo, Fabiola Ciccosanti, Giuseppina Di Giacomo, Mauro Piacentini, Gian Maria Fimia, Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases, Expert Review of Proteomics, 2010, 7, 4, 519

    CrossRef

  97. 97
    Susanne A. Schneider, Kailash P. Bhatia, Rare Causes of Dystonia Parkinsonism, Current Neurology and Neuroscience Reports, 2010, 10, 6, 431

    CrossRef

  98. 98
    Charleen T. Chu, Tickled PINK1: Mitochondrial homeostasis and autophagy in recessive Parkinsonism, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 1, 20

    CrossRef

  99. 99
    Enza Maria valente, Alessandro Ferraris, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  100. 100
    M.I. Shadrina, P.A. Slominsky, S.A. Limborska, 2010,

    CrossRef

  101. 101
    Thomas Gasser, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef

  102. 102
    Casey Cook, Leonard Petrucelli, A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009, 1792, 7, 664

    CrossRef

  103. 103
    Franz Marxreiter, Silke Nuber, Mahesh Kandasamy, Jochen Klucken, Robert Aigner, Ralf Burgmayer, Sebastien Couillard-Despres, Olaf Riess, Jürgen Winkler, Beate Winner, Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein, European Journal of Neuroscience, 2009, 29, 5
  104. 104
    Coro Paisan-Ruiz, Kailash P. Bhatia, Abi Li, Dena Hernandez, Mary Davis, Nick W. Wood, John Hardy, Henry Houlden, Andrew Singleton, Susanne A. Schneider, Characterization of PLA2G6 as a locus for dystonia-parkinsonism, Annals of Neurology, 2009, 65, 1
  105. 105
    Susanne A. Schneider, Kailash P. Bhatia, John Hardy, Complicated recessive dystonia parkinsonism syndromes, Movement Disorders, 2009, 24, 4
  106. 106
    Anthony H.V. Schapira, Etiology and Pathogenesis of Parkinson Disease, Neurologic Clinics, 2009, 27, 3, 583

    CrossRef

  107. 107
    Caroline Pirkevi, Suzanne Lesage, Alexis Brice, A. Nazli Başak, From Genes to Proteins in Mendelian Parkinson's Disease: An Overview, The Anatomical Record, 2009, 292, 12
  108. 108
    Ming-Jen Lee, Ignacio F. Mata, Chin-Hsien Lin, Kai-Yuan Tzen, Sarah J. Lincoln, Rebecca Bounds, Paul J. Lockhart, Mary M. Hulihan, Matthew J. Farrer, Ruey-Meei Wu, Genotype–phenotype correlates in Taiwanese patients with early-onset recessive parkinsonism, Movement Disorders, 2009, 24, 1
  109. 109
    Maria G. Macedo, Dagmar Verbaan, Yue Fang, Stephanie M. van Rooden, Martine Visser, Burcu Anar, Antonella Uras, Justus L. Groen, Patrizia Rizzu, Jacobus J. van Hilten, Peter Heutink, Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease, Movement Disorders, 2009, 24, 2
  110. 110
    Jason P. Covy, Benoit I. Giasson, Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2, Biochemical and Biophysical Research Communications, 2009, 378, 3, 473

    CrossRef

  111. 111
    Hansruedi Büeler, Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease, Experimental Neurology, 2009, 218, 2, 235

    CrossRef

  112. 112
    Thomas Gasser, Mendelian forms of Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009, 1792, 7, 587

    CrossRef

  113. 113
    Rebecca Banerjee, Anatoly A. Starkov, M. Flint Beal, Bobby Thomas, Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009, 1792, 7, 651

    CrossRef

  114. 114
    Thomas Gasser, Molecular pathogenesis of Parkinson disease: insights from genetic studies, Expert Reviews in Molecular Medicine, 2009, 11,

    CrossRef

  115. 115
    Hiroyuki Tomiyama, Yuanzhe Li, Hiroyo Yoshino, Yoshikuni Mizuno, Shin-ichiro Kubo, Tatsushi Toda, Nobutaka Hattori, Mutation analysis for DJ-1 in sporadic and familial parkinsonism: Screening strategy in parkinsonism, Neuroscience Letters, 2009, 455, 3, 159

    CrossRef

  116. 116
    Anthony H.V. Schapira, Neurobiology and treatment of Parkinson's disease, Trends in Pharmacological Sciences, 2009, 30, 1, 41

    CrossRef

  117. 117
    Alessandro Ferraris, Tamara Ialongo, Giulio Cesare Passali, Maria Teresa Pellecchia, Livia Brusa, Marianna Laruffa, Arianna Guidubaldi, Gaetano Paludetti, Alberto Albanese, Paolo Barone, Bruno Dallapiccola, Enza Maria Valente, Anna Rita Bentivoglio, Olfactory dysfunction in Parkinsonism caused by PINK1 mutations, Movement Disorders, 2009, 24, 16
  118. 118
    Hui Xiong, Danling Wang, Linan Chen, Yeun Su Choo, Hong Ma, Chengyuan Tang, Kun Xia, Wei Jiang, Ze’ev Ronai, Xiaoxi Zhuang, Zhuohua Zhang, Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation, Journal of Clinical Investigation, 2009, 119, 3, 650

    CrossRef

  119. 119
    Marco D'Amelio, Paolo Ragonese, Gabriella Sconzo, Paolo Aridon, Giovanni Savettieri, Parkinson's Disease and Cancer, Annals of the New York Academy of Sciences, 2009, 1155, 1
  120. You have full text access to this Open Access content120
    Vanessa A. Morais, Patrik Verstreken, Anne Roethig, Joél Smet, An Snellinx, Mieke Vanbrabant, Dominik Haddad, Christian Frezza, Wim Mandemakers, Daniela Vogt-Weisenhorn, Rudy Van Coster, Wolfgang Wurst, Luca Scorrano, Bart De Strooper, Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function, EMBO Molecular Medicine, 2009, 1, 2
  121. 121
    Sergio Papa, Vittoria Petruzzella, Salvatore Scacco, Anna Maria Sardanelli, Arcangela Iuso, Damiano Panelli, Rita Vitale, Raffaella Trentadue, Domenico De Rasmo, Nazzareno Capitanio, Claudia Piccoli, Francesco Papa, Michele Scivetti, Enrico Bertini, Teresa Rizza, Giuseppe De Michele, Pathogenetic mechanisms in hereditary dysfunctions of complex I of the respiratory chain in neurological diseases, Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2009, 1787, 5, 502

    CrossRef

  122. 122
    Clecio Godeiro-Junior, Patricia M. de Carvalho-Aguiar, Andre C. Felício, Orlando G.P. Barsottini, Sonia M.A. Silva, Vanderci Borges, Luiz Augusto F. Andrade, Henrique Ballalai Ferraz, PINK1 mutations in a Brazilian cohort of early-onset Parkinson's disease patients, Movement Disorders, 2009, 24, 11
  123. 123
    Enza Maria Valente, Silvia Michiorri, Giuseppe Arena, Vania Gelmetti, PINK1: one protein, multiple neuroprotective functions, Future Neurology, 2009, 4, 5, 575

    CrossRef

  124. 124
    Kelly Jean Thomas, Mark R. Cookson, The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics, The International Journal of Biochemistry & Cell Biology, 2009, 41, 10, 2025

    CrossRef

  125. 125
    Serena ROSNER, Nir GILADI, Avi ORR-URTREGER, Advances in the genetics of Parkinson's disease, Acta Pharmacologica Sinica, 2008, 29, 1
  126. 126
    Amy K. Reeve, Kim J. Krishnan, Doug M. Turnbull, Age related mitochondrial degenerative disorders in humans, Biotechnology Journal, 2008, 3, 6
  127. 127
    Jung Mi Choi, Myoung Soo Woo, Hyeo-Il Ma, Suk Yun Kang, Young-Hee Sung, Seok Woo Yong, Sun Ju Chung, Joong-Seok Kim, Hae-won Shin, Chul Hyoung Lyoo, Phil Hyu Lee, Jong Sam Baik, Sang-Jin Kim, Mee Young Park, Young Ho Sohn, Jin-Ho Kim, Jae Woo Kim, Myung Sik Lee, Myoung Chong Lee, Dong-Hyun Kim, Yun Joong Kim, Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease, Neurogenetics, 2008, 9, 4, 263

    CrossRef

  128. 128
    Ryan D. Mills, Chou Hung Sim, Su San Mok, Terrence D. Mulhern, Janetta G. Culvenor, Heung-Chin Cheng, Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1), Journal of Neurochemistry, 2008, 105, 1
  129. 129
    J. Prestel, K. Gempel, T. K. Hauser, K. Schweitzer, H. Prokisch, U. Ahting, D. Freudenstein, E. Bueltmann, T. Naegele, D. Berg, T. Klopstock, T. Gasser, Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation, Journal of Neurology, 2008, 255, 5, 643

    CrossRef

  130. 130
    Evan L. Thacker, Alberto Ascherio, Familial aggregation of Parkinson's disease: A meta-analysis, Movement Disorders, 2008, 23, 8
  131. 131
    Saskia Biskup, Manfred Gerlach, Andreas Kupsch, Heinz Reichmann, Peter Riederer, Peter Vieregge, Ullrich Wüllner, Thomas Gasser, Genes associated with Parkinson syndrome, Journal of Neurology, 2008, 255, S5, 8

    CrossRef

  132. 132
    Ayse Ulusoy, Tomas Bjorklund, Stephan Hermening, Deniz Kirik, In vivo gene delivery for development of mammalian models for Parkinson's disease, Experimental Neurology, 2008, 209, 1, 89

    CrossRef

  133. 133
    Marie Westerlund, Caroline Ran, Anders Borgkvist, Fredrik H. Sterky, Eva Lindqvist, Karin Lundströmer, Karin Pernold, Stefan Brené, Pekka Kallunki, Gilberto Fisone, Lars Olson, Dagmar Galter, Lrrk2 and α-synuclein are co-regulated in rodent striatum, Molecular and Cellular Neuroscience, 2008, 39, 4, 586

    CrossRef

  134. 134
    Anthony HV Schapira, Mitochondria in the aetiology and pathogenesis of Parkinson's disease, The Lancet Neurology, 2008, 7, 1, 97

    CrossRef

  135. 135
    Claudia Piccoli, Annamaria Sardanelli, Rosella Scrima, Maria Ripoli, Giovanni Quarato, Annamaria D’Aprile, Francesco Bellomo, Salvatore Scacco, Giuseppe De Michele, Alessandro Filla, Arcangela Iuso, Domenico Boffoli, Nazzareno Capitanio, Sergio Papa, Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation, Neurochemical Research, 2008, 33, 12, 2565

    CrossRef

  136. 136
    Ji-Feng Guo, Bin Xiao, Bing Liao, Xue-Wei Zhang, Li-Luo Nie, Yu-Hu Zhang, Lu Shen, Hong Jiang, Kun Xia, Qian Pan, Xin-Xiang Yan, Bei-Sha Tang, Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset Parkinsonism, Movement Disorders, 2008, 23, 14
  137. 137
    José A. G. Agúndez, Antonio Luengo, Oscar Herráez, Carmen Martínez, Hortensia Alonso-Navarro, Félix Javier Jiménez-Jiménez, Elena García-Martín, Nonsynonymous Polymorphisms of Histamine-Metabolising Enzymes in Patients with Parkinson’s Disease, NeuroMolecular Medicine, 2008, 10, 1, 10

    CrossRef

  138. 138
    Andrea C. Belin, Marie Westerlund, Parkinson’s disease: A genetic perspective, FEBS Journal, 2008, 275, 7
  139. 139
    John Bell, Amy M. Todd, Brian E. Staveley, Pink1suppressesα-synuclein-induced phenotypes in aDrosophilamodel of Parkinson’s disease, Genome, 2008, 51, 12, 1040

    CrossRef

  140. 140
    Y. Mizuno, N. Hattori, S.-i. Kubo, S. Sato, K. Nishioka, T. Hatano, H. Tomiyama, M. Funayama, Y. Machida, H. Mochizuki, Progress in the pathogenesis and genetics of Parkinson's disease, Philosophical Transactions of the Royal Society B: Biological Sciences, 2008, 363, 1500, 2215

    CrossRef

  141. 141
    Carola Schiesling, Nicole Kieper, Kay Seidel, Rejko Krüger, Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease, Neuropathology and Applied Neurobiology, 2008, 34, 3
  142. 142
    I. Tuin, U. Voss, K. Kessler, K. Krakow, R. Hilker, B. Morales, H. Steinmetz, G. Auburger, Sleep quality in a family with hereditary parkinsonism (PARK6), Sleep Medicine, 2008, 9, 6, 684

    CrossRef

  143. 143
    M. Fiorio, E. M. Valente, M. Gambarin, A. R. Bentivoglio, T. Ialongo, A. Albanese, P. Barone, M. T. Pellecchia, F. Brancati, G. Moretto, A. Fiaschi, M. Tinazzi, Subclinical sensory abnormalities in unaffected PINK1 heterozygotes, Journal of Neurology, 2008, 255, 9, 1372

    CrossRef

  144. 144
    Iain P. Hargreaves, Amelia Lane, Patrick M.A. Sleiman, The coenzyme Q10 status of the brain regions of Parkinson’s disease patients, Neuroscience Letters, 2008, 447, 1, 17

    CrossRef

  145. 145
    H. Deng, M. W. Dodson, H. Huang, M. Guo, The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila, Proceedings of the National Academy of Sciences, 2008, 105, 38, 14503

    CrossRef

  146. 146
    Owen A. Ross, Adam T. Braithwaite, Matthew J. Farrer, Parkinson's Disease, 2008,

    CrossRef

  147. 147
    Anne Grünewald, Guido J. Breedveld, Katja Lohmann-Hedrich, Christan F. Rohé, Inke R. König, Johann Hagenah, Nicola Vanacore, Giuseppe Meco, Angelo Antonini, Stefano Goldwurm, Suzanne Lesage, Alexandra Dürr, Ferdinand Binkofski, Hartwig Siebner, Alexander Münchau, Alexis Brice, Ben A. Oostra, Christine Klein, Vincenzo Bonifati, Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis, Neurogenetics, 2007, 8, 2, 103

    CrossRef

  148. 148
    Christine Klein, Katja Lohmann-Hedrich, Ekaterina Rogaeva, Michael G Schlossmacher, Anthony E Lang, Deciphering the role of heterozygous mutations in genes associated with parkinsonism, The Lancet Neurology, 2007, 6, 7, 652

    CrossRef

  149. 149
    JA Timmons, C Scheele, C Wahlestedt, Do mitochondria provide a common link between diabetes and Parkinson's disease?, Practical Diabetes International, 2007, 24, 7
  150. 150
    T. Kitada, A. Pisani, D. R. Porter, H. Yamaguchi, A. Tscherter, G. Martella, P. Bonsi, C. Zhang, E. N. Pothos, J. Shen, Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice, Proceedings of the National Academy of Sciences, 2007, 104, 27, 11441

    CrossRef

  151. 151
    S. Lesage, A. Dürr, A. Brice, LRRK2: a link between familial and sporadic Parkinson’s disease?, Pathologie Biologie, 2007, 55, 2, 107

    CrossRef

  152. 152
    A H V Schapira, Mitochondrial dysfunction in Parkinson's disease, Cell Death and Differentiation, 2007, 14, 7, 1261

    CrossRef

  153. 153
    Amy B. Manning-BoĞ, J. William Langston, Model fusion: The next phase in developing animal models for parkinson’s disease, Neurotoxicity Research, 2007, 11, 3-4, 219

    CrossRef

  154. 154
    M. C. Shih, A. C. Felicio, C. De Oliveira Godeiro-Junior, P. De Carvalho Aguiar, L. A. F. De Andrade, H. B. Ferraz, R. A. Bressan, Molecular imaging in hereditary forms of parkinsonism, European Journal of Neurology, 2007, 14, 4
  155. 155
    Malú G. Tansey, Melissa K. McCoy, Tamy C. Frank-Cannon, Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention, Experimental Neurology, 2007, 208, 1, 1

    CrossRef

  156. 156
    Lilach Ephraty, Omer Porat, David Israeli, Oren S. Cohen, Olga Tunkel, Shinar Yael, Yasaku Hatano, Nobutaka Hattori, Sharon Hassin-Baer, Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations, Movement Disorders, 2007, 22, 4
  157. 157
    Eng-King Tan, Lisa M. Skipper, Pathogenic mutations in Parkinson disease, Human Mutation, 2007, 28, 7
  158. 158
    Hung-Li Wang, An-Hsun Chou, Tu-Hsueh Yeh, Allen H. Li, Ying-Ling Chen, Yu-Li Kuo, Shu-Ru Tsai, Szu-Tzu Yu, PINK1 mutants associated with recessive Parkinson’s disease are defective in inhibiting mitochondrial release of cytochrome c, Neurobiology of Disease, 2007, 28, 2, 216

    CrossRef

  159. 159
    Yi-Hsin Weng, Yah-Huei Wu Chou, Wen-Shiang Wu, Kun-Ju Lin, Hsiu-Chen Chang, Tzu-Chen Yen, Rou-Shayn Chen, Shiaw-Pyng Wey, Chin-Song Lu, PINK1 mutation in Taiwanese early-onset parkinsonism, Journal of Neurology, 2007, 254, 10, 1347

    CrossRef

  160. You have free access to this content160
    Thomas Gasser, Update on the genetics of Parkinson's disease, Movement Disorders, 2007, 22, S17
  161. 161
    Anthony H.V. Schapira, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  162. 162
    Joseph Jankovic, Textbook of Clinical Neurology, 2007,

    CrossRef

  163. 163
    Yue Huang, Piu Chan, Glenda Halliday, Oxidative Stress and Neurodegenerative Disorders, 2007,

    CrossRef

  164. 164
    Yoshikuni Mizuno, Nobutaka Hattori, Hideki Mochizuki, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  165. 165
    Essam A Sheta, Stanley H Appel, Ira L Goldknopf, 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases, Expert Review of Proteomics, 2006, 3, 1, 45

    CrossRef

  166. 166
    Feng Wang, Xiuli Feng, Jinhong Ma, Haiqiang Zou, Piu Chan, A common A340T variant in PINK1 gene associated with late-onset Parkinson's disease in Chinese, Neuroscience Letters, 2006, 410, 2, 121

    CrossRef

  167. 167
    Patrick M. Abou-Sleiman, Miratul M. K. Muqit, Neil Q. McDonald, Yan Xiang Yang, Sonia Gandhi, Daniel G. Healy, Kirsten Harvey, Robert J. Harvey, Emma Deas, Kailash Bhatia, Niall Quinn, Andrew Lees, David S. Latchman, Nicholas W. Wood, A heterozygous effect for PINK1 mutations in Parkinson's disease?, Annals of Neurology, 2006, 60, 4
  168. 168
    Miratul M. K. Muqit, Patrick M. Abou-Sleiman, Adrian T. Saurin, Kirsten Harvey, Sonia Gandhi, Emma Deas, Simon Eaton, Martin D. Payne Smith, Kerrie Venner, Antoni Matilla, Daniel G. Healy, William P. Gilks, Andrew J. Lees, Janice Holton, Tamas Revesz, Peter J. Parker, Robert J. Harvey, Nicholas W. Wood, David S. Latchman, Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress, Journal of Neurochemistry, 2006, 98, 1
  169. 169
    Hon-Chung Fung, Chiung-Mei Chen, John Hardy, Andrew B. Singleton, Guey-Jen Lee-Chen, Yih-Ru Wu, Analysis of the PINK1 gene in a cohort of patients with sporadic early-onset parkinsonism in Taiwan, Neuroscience Letters, 2006, 394, 1, 33

    CrossRef

  170. 170
    D. Wang, L. Qian, H. Xiong, J. Liu, W. S. Neckameyer, S. Oldham, K. Xia, J. Wang, R. Bodmer, Z. Zhang, Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila, Proceedings of the National Academy of Sciences, 2006, 103, 36, 13520

    CrossRef

  171. 171
    Anette Schrag, Jonathan M Schott, Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism, The Lancet Neurology, 2006, 5, 4, 355

    CrossRef

  172. 172
    Albert Lladó, Carles Gaig, José L. Molinuevo, Genética de las enfermedades neurodegenerativas más prevalentes, Medicina Clínica, 2006, 126, 17, 662

    CrossRef

  173. 173
    Matthew James Farrer, Genetics of Parkinson disease: paradigm shifts and future prospects, Nature Reviews Genetics, 2006, 7, 4, 306

    CrossRef

  174. 174
    John Hardy, Huaiban Cai, Mark R. Cookson, Katrina Gwinn-Hardy, Andrew Singleton, Genetics of Parkinson's disease and parkinsonism, Annals of Neurology, 2006, 60, 4
  175. 175
    Ana Djarmati, Katja Hedrich, Marina Svetel, Thora Lohnau, Eberhard Schwinger, Stanka Romac, Peter P. Pramstaller, Vladimir Kostić, Christine Klein, Heterozygous PINK1 mutations: A susceptibility factor for Parkinson disease?, Movement Disorders, 2006, 21, 9
  176. 176
    Cindy Zadikoff, Ekaterina Rogaeva, Ana Djarmati, Christine Sato, Shabnam Salehi-Rad, Peter St. George-Hyslop, Christine Klein, Anthony E. Lang, Homozygous and heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients, Movement Disorders, 2006, 21, 6
  177. 177
    Hideaki Kobayashi, Hiroshi Ujike, Junko Hasegawa, Mitsutoshi Yamamoto, Akihiro Kanzaki, Ichiro Sora, Identification of a risk haplotype of the α-synuclein gene in Japanese with sporadic Parkinson's disease, Movement Disorders, 2006, 21, 12
  178. 178
    M. I. Shadrina, P. A. Slominsky, Molecular genetics of Parkinson’s disease, Russian Journal of Genetics, 2006, 42, 8, 858

    CrossRef

  179. 179
    Annabella N. Sellbach, Richard S. Boyle, Peter A. Silburn, George D. Mellick, Parkinson's disease and family history, Parkinsonism & Related Disorders, 2006, 12, 7, 399

    CrossRef

  180. 180
    D. Gosal, O. A. Ross, M. Toft, Parkinson's disease: the genetics of a heterogeneous disorder, European Journal of Neurology, 2006, 13, 6
  181. 181
    Asa Abeliovich, M. Flint Beal, Parkinsonism genes: culprits and clues, Journal of Neurochemistry, 2006, 99, 4
  182. 182
    Chiara Criscuolo, Giampiero Volpe, Anna De Rosa, Andrea Varrone, Roberta Marongiu, Pietro Mancini, Elena Salvatore, Bruno Dallapiccola, Alessandro Filla, Enza Maria Valente, Giuseppe De Michele, PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism, Movement Disorders, 2006, 21, 8
  183. 183
    Eng-King Tan, Kenneth Yew, Eva Chua, K. Puvan, Hui Shen, Esther Lee, Kim-Yoong Puong, Yi Zhao, Ratnagopal Pavanni, Meng-Cheong Wong, Dominic Jamora, Deidre de Silva, Kyaw-Thu Moe, Fung-Peng Woon, Yih Yuen, Louis Tan, PINK1 mutations in sporadic early-onset Parkinson's disease, Movement Disorders, 2006, 21, 6
  184. 184
    Shin-Ichiro Kubo, Nobutaka Hattori, Yoshikuni Mizuno, Recessive Parkinson's disease, Movement Disorders, 2006, 21, 7
  185. 185
    Christine Klein, Michael G Schlossmacher, The genetics of Parkinson disease: implications for neurological care, Nature Clinical Practice Neurology, 2006, 2, 3, 136

    CrossRef

  186. 186
    EK Tan, K Yew, E Chua, H Shen, RD Jamora, E Lee, KY Puong, Y Zhao, R Pavanni, MC Wong, K Puvan, Y Yih, LCS Tan, Analysis of PINK1 in Asian patients with familial parkinsonism, Clinical Genetics, 2005, 68, 5
  187. 187
    H. Deng, W. D. Le, X. Zhang, T. H. Pan, J. Jankovic, G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients, Acta Neurologica Scandinavica, 2005, 111, 6
  188. 188
    Hao Deng, Wei-Dong Le, Wen-Jie Xie, Tian-Hong Pan, Xiong Zhang, Joseph Jankovic, Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonism, Neuroscience Letters, 2005, 382, 3, 297

    CrossRef

  189. 189
    Aideen McInerney-Leo, Donald W. Hadley, Katrina Gwinn-Hardy, John Hardy, Genetic testing in Parkinson's disease, Movement Disorders, 2005, 20, 1
  190. 190
    Alistair J. Lewthwaite, David J. Nicholl, Genetics of Parkinsonism, Current Neurology and Neuroscience Reports, 2005, 5, 5, 397

    CrossRef

  191. 191
    Thomas Gasser, Genetics of Parkinsonʼs disease, Current Opinion in Neurology, 2005, 18, 4, 363

    CrossRef

  192. 192
    Mark R Cookson, Georgia Xiromerisiou, Andrew Singleton, How genetics research in Parkinsonʼs disease is enhancing understanding of the common idiopathic forms of the disease, Current Opinion in Neurology, 2005, 18, 6, 706

    CrossRef

  193. 193
    Jennifer Kachergus, Ignacio F. Mata, Mary Hulihan, Julie P. Taylor, Sarah Lincoln, Jan Aasly, J. Mark Gibson, Owen A. Ross, Timothy Lynch, Joseph Wiley, Haydeh Payami, John Nutt, Demetrius M. Maraganore, Krzysztof Czyzewski, Maria Styczynska, Zbigniew K. Wszolek, Matthew J. Farrer, Mathias Toft, Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations, The American Journal of Human Genetics, 2005, 76, 4, 672

    CrossRef

  194. 194
    Darren J. Moore, Andrew B. West, Valina L. Dawson, Ted M. Dawson, MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE, Annual Review of Neuroscience, 2005, 28, 1, 57

    CrossRef

  195. 195
    Christine Klein, Ana Djarmati, Katja Hedrich, Nora Schäfer, Cesa Scaglione, Roberta Marchese, Norman Kock, Birgitt Schüle, Anja Hiller, Thora Lohnau, Susen Winkler, Karin Wiegers, Robert Hering, Peter Bauer, Olaf Riess, Giovanni Abbruzzese, Paolo Martinelli, Peter P Pramstaller, PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism, European Journal of Human Genetics, 2005, 13, 9, 1086

    CrossRef

  196. 196
    S. Gandhi, P. M. Abou-Sleiman, D. G. Healy, M. Weale, W. Gilks, K. Ahmadi, D. B. Goldstein, N. W. Wood, Population genetic approaches to neurological disease: Parkinson's disease as an example, Philosophical Transactions of the Royal Society B: Biological Sciences, 2005, 360, 1460, 1573

    CrossRef

  197. 197
    John Hardy, J. William Langston, How many pathways are there to nigral death?, Annals of Neurology, 2004, 56, 3
  198. 198
    Daniel G Healy, Patrick M Abou-Sleiman, Nicholas W Wood, PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism, The Lancet Neurology, 2004, 3, 11, 652

    CrossRef

  199. 199
    Claudia M. Testa, Parkinson's Disease: Genetics and Pathogenesis, Handbook of Contemporary Neuropharmacology,